These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4285350)

  • 1. The estimation of the kallidins in blood and urine.
    Webster ME; Gilmore JP
    Biochem Pharmacol; 1965 Jul; 14(7):1161-3. PubMed ID: 4285350
    [No Abstract]   [Full Text] [Related]  

  • 2. POTENTIATION OF THE ACTION OF BRADYKININ ON SMOOTH MUSCLE BY CHYMOTRYPSIN, CHYMOTRYPSINOGEN AND TRYPSIN.
    EDERY H
    Br J Pharmacol Chemother; 1964 Apr; 22(2):371-9. PubMed ID: 14190472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FURTHER STUDIES OF THE SENSITIZATION OF SMOOTH MUSCLE TO THE ACTION OF PLASMA KININS BY PROTEOLYTIC ENZYMES.
    EDERY H
    Br J Pharmacol Chemother; 1965 Apr; 24(2):485-96. PubMed ID: 14320863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasoactive polypeptides from blood substrates].
    Croxatto H
    Ann Ist Super Sanita; 1966; 2(4):575-98. PubMed ID: 4307926
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of combined renal vasodilatation and pressor agents on renal hemodynamics and the tubular reabsorption of sodium.
    Earley LE; Friedler RM
    J Clin Invest; 1966 Apr; 45(4):542-51. PubMed ID: 4287059
    [No Abstract]   [Full Text] [Related]  

  • 6. The detection and estimation of bradykinin in the circulating blood.
    Ferreira SH; Vane JR
    Br J Pharmacol Chemother; 1967 Mar; 29(3):367-77. PubMed ID: 4382328
    [No Abstract]   [Full Text] [Related]  

  • 7. BRADYKININOGEN, ANGIOTENSINOGEN AND KALLIDINOGEN.
    FASCIOLO JC
    Br J Pharmacol Chemother; 1963 Oct; 21(2):250-8. PubMed ID: 14081656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for substrates and inhibitors of angiotensin I-converting enzyme in vivo and vitro.
    Oparil S; Koerner T; O'Donoghue JK
    Circ Res; 1974 Jan; 34(1):19-26. PubMed ID: 4358469
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trypsin, chymotrypsin, kallidin and bradykinin].
    WERLE E; KEHL R; KOEBKE K
    Biochem Z; 1950; 321(3):213-20. PubMed ID: 14800984
    [No Abstract]   [Full Text] [Related]  

  • 10. AN IN VIVO ESTIMATION OF THE POTENCIES AND HALF-LIVES OF SYNTHETIC BRADYKININ AND KALLIDIN.
    MCCARTHY DA; POTTER DE; NICOLAIDES ED
    J Pharmacol Exp Ther; 1965 Apr; 148():117-22. PubMed ID: 14279175
    [No Abstract]   [Full Text] [Related]  

  • 11. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II.
    Stewart JM; Ferreira SH; Greene LJ
    Biochem Pharmacol; 1971 Jul; 20(7):1557-67. PubMed ID: 4355304
    [No Abstract]   [Full Text] [Related]  

  • 12. [PURIFICATION OF HUMAN URINARY GONADOTROPIN (HMG) OF THE MENOPAUSE BY AMBERLITE IRC-50 AND DIETHYLAMINOETHYLCELLULOSE CHROMATOGRAPHY].
    JUTISZ M; THEOLEYRE M; COLONGE A; COURRIER R
    C R Hebd Seances Acad Sci; 1963 Jul; 257():991-5. PubMed ID: 14051480
    [No Abstract]   [Full Text] [Related]  

  • 13. Kinins released from horse heat-acid-denaturated plasma by plasmin, plasma kallikrein, trypsin and Bothrops kininogenase.
    Gapanhuk E; Henriques OB
    Biochem Pharmacol; 1970 Jun; 19(6):2091-6. PubMed ID: 4254789
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative study of kinin, kallidin, and bradykinin.
    HOLDSTOCK DJ; MATHIAS AP; SCHACHTER M
    Br J Pharmacol Chemother; 1957 Jun; 12(2):149-58. PubMed ID: 13446366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro production of angiotensin I by renal glomeruli.
    Finkielman S; Nahmod VE
    Nature; 1969 Jun; 222(5199):1186-8. PubMed ID: 4307029
    [No Abstract]   [Full Text] [Related]  

  • 16. Liberation of a bradykinin-like substance in the circulating blood of dogs by trypsin, chymotrypsin and nagarse.
    Ferreira SH; Rocha E Silva M
    Br J Pharmacol; 1969 Jul; 36(3):611-22. PubMed ID: 5789813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DETERMINATION OF SEROTONIN IN BLOOD USING AN ION-EXCHANGE RESIN.
    DAVIS VE; HUFF JA; BROWN H; ALFREY CP
    Clin Chim Acta; 1964 May; 9():419-26. PubMed ID: 14185806
    [No Abstract]   [Full Text] [Related]  

  • 18. THE ESTIMATION OF BRADYKININOGEN CONTENT OF THE PLASMA.
    FASCIOLO JC; ESPADA J; CARRETERO O
    Acta Physiol Lat Am; 1963; 13():215-20. PubMed ID: 14125842
    [No Abstract]   [Full Text] [Related]  

  • 19. Analgesic-antipyretic drugs as inhibitors of kallikrein.
    NORTHOVER BJ; SUBRAMANIAN G
    Br J Pharmacol Chemother; 1961 Aug; 17(1):107-15. PubMed ID: 13729628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergist for serotonin present in schizophrenic blood.
    Woolley DW; Gommi BW
    Proc Natl Acad Sci U S A; 1966 Jul; 56(1):191-7. PubMed ID: 5229847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.